A Closer Look at the FDA’s Center for Devices and Radiological Health’s Unprecedented Efforts in the COVID-19 Response | FDA

A Closer Look at the FDA’s Center for Devices and Radiological Health’s Unprecedented Efforts in the COVID-19 Response | FDA

Coronavirus Disease 2019 (COVID-19) updates Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last email update include: September 29, 2020: A Closer Look at the FDA’s Center for Devices and Radiological Health’s Unprecedented Efforts in the COVID-19 Response September 25, 2020: Daily Roundup - FDA issues an updated summary of the agency’s COVID-19 response efforts September 24, 2020: FDA published a Patient Outreach Toolkit for health care professionals, with useful COVID-19 resources to share with your patients and others in your community September 23, 2020: FDA Authorizes First Point-of-Care Antibody Test for COVID-19 September 23, 2020: COVID-19: An Update on the Federal Response - Hearing before the Senate Committee on Health, Education, Labor and Pensions; FDA Commissioner Stephen M. Hahn, M.D., testified Bookmark www.fda.gov/coronavirus for the latest. A closer look at the FDA’s Center for Devices and Radiological Health’s unprecedented efforts in the COVID-19 response By: Stephen M. Hahn, M.D., Commissioner of Food and Drugs If you want to know the FDA’s impact on COVID-19, look no further than the numbers. In a few short months, the agency’s Center for Devices and Radiological Health’s (CDRH) response to the pandemic has been unprecedented in terms of volume, speed, and agility – spanning multiple areas, including: regulatory flexibility, Emergency Use Authorizations (EUAs) for devices, shortage mitigation activities, Public Health Service Corps deployment, and extensive engagement with stakeholders. Additionally, over 50 percent of CDRH employees have dedicated an incredible number of hours to the COVID-19 response, in addition to performing their existing responsibilities at the FDA. (September 29, 2020) Read More Patient Outreach Toolkit FDA developed new health education materials tailored for diverse consumers, available in English and Spanish. Health care professionals can use the materials to talk with patients about COVID-19 health fraud, vaccine development, testing, and other aspects of FDA’s response. (September 24, 2020) View the toolkit